The presence of tumor-associated lymphatic vessels also promotes the exit of CD8+ T cells via the CXCL12 – CXCR4 chemotaxis, reducing the retention of tumor-specific CD8+ T cells (97). The gene discussed is CXCR4; the disease is neoplasm.